Dr. Patricia K. Coyle, multiple sclerosis clinician and researcher to lecture on DMTs
Credit: CMSC Optimal use of disease-modifying therapies (DMTs) may be one of the single most important clinical decisions made in treating multiple sclerosis (MS). Currently,...










